Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CEL SCI CORP (CVM)

$1.64 +1.86% NYSE: CVM · 15-min delayed
  • VIENNA, Virginia
  • Public · NYSE: CVM
  • 44 employees
$20.6MMarket cap
$264.0KRevenue · FY2014
-$25.4MNet income
44Employees
CVMNYSE
1983IPO

About CEL SCI CORP

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2014
$264.0K
Net income
-$25.4M
Total assets
$28.2M
Market cap
$20.6M

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: CVM
$1.64 +1.86%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.97 $10.47

52-week range

Market cap
$20.6M
Shares outstanding
12.6M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Dec 8, 1983

CEL SCI Corp (CVM) Stock Price

  • Reported a net loss of $25.4M in FY2014.
  • Trading 84% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CEL SCI CORP.

Write a review
Newsroom

News about CEL SCI CORP

News & sentiment via Polygon.io

FAQ

CEL SCI Corp: frequently asked questions

Is CEL SCI Corp an American company?

CEL SCI Corp is a US-based company headquartered in Vienna, Virginia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is CEL SCI Corp headquartered?

CEL SCI Corp is headquartered in Vienna, Virginia, United States.

Is CEL SCI Corp publicly traded?

Yes — CEL SCI Corp is a publicly traded company. Its stock trades under the ticker symbol CVM on the NYSE.

What does CEL SCI Corp do?

CEL SCI Corp is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →